Mechanism of SMRT Corepressor Recruitment by the BCL6 BTB Domain

Molecular Cell

Volumn 12, Issue 6, 2003, Pages 1551-1564

  Ahmad, K Farid ^a,b   Melnick, Ari ^e   Lax, Stuart ^b   Bouchard, Denis ^c   Liu, Jun ^a   Kiang, Chih Li ^e   Mayer, Sebastian ^e   Takahashi, Shinichiro ^d   Licht, Jonathan D ^d   Privé, Gilbert G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c Advanced Medical Discovery Institute   (Canada)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; PROTEIN DERIVATIVE; PROTEIN SMRT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BCL6; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; GENE REPRESSION; HUMAN; HUMAN CELL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

EID: 9144242434     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00454-4     Document Type: Article

References (64)

1. Adams J., Kelso R., Cooley L. The kelch repeat superfamily of proteins. propellers of cell function Trends Cell Biol. 10:2000;17-24.
2. Ahmad K.F., Engel C.K., Privé G.G. Crystal structure of the BTB domain from PLZF. Proc. Natl. Acad. Sci. USA. 95:1998;12123-12128.
3. Albagli-Curiel O. Ambivalent role of BCL6 in cell survival and transformation. Oncogene. 22:2003;507-516.
4. Ball H.J., Melnick A., Shaknovich R., Kohanski R.A., Licht J.D. The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase. Nucleic Acids Res. 27:1999;4106-4113.
5. Ball L.J., Jarchau T., Oschkinat H., Walter U. EVH1 domains. structure, function and interactions FEBS Lett. 513:2002;45-52.
6. Bardwell V.J., Treisman R. The POZ domain. a conserved protein-protein interaction motif Genes Dev. 8:1994;1664-1677.
7. Baron B.W., Anastasi J., Thirman M.J., Furukawa Y., Fears S., Kim D.C., Simone F., Birkenbach M., Montag A., Sadhu A.et al. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression. implications for a role of BCL6 in the down-regulation of apoptosis Proc. Natl. Acad. Sci. USA. 99:2002;2860-2865.
8. Brünger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D. 54:1998;905-921.
9. Calame K.L., Lin K.I., Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21:2003;205-230.
10. Costoya J.A., Pandolfi P.P. The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development. Curr. Opin. Hematol. 8:2001;212-217.
11. Cull M.G., Schatz P.J. Biotinylation of proteins in vivo and in vitro using small peptide tags. Methods Enzymol. 326:2000;430-440.
12. David G., Alland L., Hong S.H., Wong C.W., DePinho R.A., Dejean A. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene. 16:1998;2549-2556.
13. DeLano W.L. The PyMOL Molecular Graphics System. 2002;DeLano Scientific, San Carlos.
14. Deltour S., Guerardel C., Leprince D. Recruitment of SMRT/N-CoR-mSin3A- HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors. the case of HIC-1 and gammaFBP-B Proc. Natl. Acad. Sci. USA. 96:1999;14831-14836.
15. Dent A.L., Vasanwala F.H., Toney L.M. Regulation of gene expression by the proto-oncogene BCL-6. Crit. Rev. Oncol. Hematol. 41:2002;1-9.
16. Dhordain P., Albagli O., Ansieau S., Koken M.H., Deweindt C., Quief S., Lantoine D., Leutz A., Kerckaert J.P., Leprince D. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo. Oncogene. 11:1995;2689-2697.
17. Dhordain P., Albagli O., Lin R.J., Ansieau S., Quief S., Leutz A., Kerckaert J.P., Evans R.M., Leprince D. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl. Acad. Sci. USA. 94:1997;10762-10767.
18. Dhordain P., Lin R.J., Quief S., Lantoine D., Kerckaert J.P., Evans R.M., Albagli O. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res. 26:1998;4645-4651.
19. Fearon D.T., Manders P., Wagner S.D. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science. 293:2001;248-250.
20. Grignani F., De Matteis S., Nervi C., Tomassoni L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F.F., Zamir I.et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature. 391:1998;815-818.
21. Guidez F., Ivins S., Zhu J., Soderstrom M., Waxman S., Zelent A. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood. 91:1998;2634-2642.
22. Hamilton A.C., Inglese J., Ferrer M. A PDZ domain-based assay for measuring HIV protease activity. assay design considerations Protein Sci. 12:2003;458-467.
23. He L.Z., Guidez F., Tribioli C., Peruzzi D., Ruthardt M., Zelent A., Pandolfi P.P. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co- repressors determine differential responses to RA in APL. Nat. Genet. 18:1998;126-135.
24. Hong S.H., David G., Wong C.W., Dejean A., Privalsky M.L. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA. 94:1997;9028-9033.
25. Huynh K.D., Bardwell V.J. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene. 17:1998;2473-2484.
26. Huynh K.D., Fischle W., Verdin E., Bardwell V.J. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 14:2000;1810-1823.
27. Kaplan J., Calame K. The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression. Nucleic Acids Res. 25:1997;1108-1116.
28. Kay B.K., Williamson M.P., Sudol M. The importance of being proline. the interaction of proline-rich motifs in signaling proteins with their cognate domains FASEB J. 14:2000;231-241.
29. Kobayashi A., Yamagiwa H., Hoshino H., Muto A., Sato K., Morita M., Hayashi N., Yamamoto M., Igarashi K. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain. Mol. Cell. Biol. 20:2000;1733-1746.
30. Kraulis P.J. Molscript. a program to produce both detailed and schematic plots of protein structures J. Appl. Cryst. 24:1991;946-950.
31. Kreusch A., Pfaffinger P.J., Stevens C.F., Choe S. Crystal structure of the tetramerization domain of the Shaker potassium channel. Nature. 392:1998;945-948.
32. Kuppers R., Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 20:2001;5580-5594.
33. Ladbury J.E., Lemmon M.A., Zhou M., Green J., Botfield M.C., Schlessinger J. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains. a reappraisal Proc. Natl. Acad. Sci. USA. 92:1995;3199-3203.
34. Lemercier C., Brocard M.P., Puvion-Dutilleul F., Kao H.Y., Albagli O., Khochbin S. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J. Biol. Chem. 277:2002;22045-22052.
35. Li J.Y., English M.A., Ball H.J., Yeyati P.L., Waxman S., Licht J.D. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J. Biol. Chem. 272:1997;22447-22455.
36. Li X., Peng H., Schultz D.C., Lopez-Guisa J.M., Rauscher F.J. 3rd, Marmorstein R. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein. Cancer Res. 59:1999;5275-5282.
37. Lin R.J., Sternsdorf T., Tini M., Evans R.M. Transcriptional regulation in acute promyelocytic leukemia. Oncogene. 20:2001;7204-7215.
38. Lin R.J., Nagy L., Inoue S., Shao W., Miller W.H. Jr., Evans R.M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 391:1998;811-814.
39. Mahmoudi T., Katsani K.R., Verrijzer C.P. GAGA can mediate enhancer function in trans by linking two separate DNA molecules. EMBO J. 21:2002;1775-1781.
40. Melnick A., Licht J.D. Deconstructing a disease. RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood. 93:1999;3167-3215.
41. Melnick A., Ahmad K.F., Arai S., Polinger A., Ball H., Borden K.L., Carlile G.W., Privé G.G., Licht J.D. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions. Mol. Cell. Biol. 20:2000;6550-6567.
42. Melnick A., Carlile G., Ahmad K.F., Kiang C.L., Corcoran C., Bardwell V., Privé G.G., Licht J.D. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 22:2002;1804-1818.
43. Merritt E.A., Bacon D.J. Raster3D. photorealistic molecular graphics Methods Enzymol. 277:1997;507-524.
44. Niu H. The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol. Oncol. 20:2002;155-166.
45. Niu H., Cattoretti G., Dalla-Favera R. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells. J. Exp. Med. 198:2003;211-221.
46. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Part A., Carter C.W., Sweet R.M. Macromolecular Crystallography. 1997;307-326 Academic Press, San Diego.
47. Pasqualucci L., Migliazza A., Basso K., Houldsworth J., Chaganti R.S., Dalla-Favera R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood. 101:2003;2914-2923.
48. Pawson T., Nash P. Assembly of cell regulatory systems through protein interaction domains. Science. 300:2003;445-452.
49. Prehoda K.E., Lee D.J., Lim W.A. Structure of the enabled/VASP homology 1 domain-peptide complex. a key component in the spatial control of actin assembly Cell. 97:1999;471-480.
50. Scheldrick G.M., Schneider T.R. Shelxl. high-resolution refinement Methods Enzymol. 277:1997;319-343.
51. Shaffer A.L., Yu X., He Y., Boldrick J., Chan E.P., Staudt L.M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 13:2000;199-212.
52. Shaffer A.L., Lin K.I., Kuo T.C., Yu X., Hurt E.M., Rosenwald A., Giltnane J.M., Yang L., Zhao H., Calame K., Staudt L.M. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 17:2002;51-62.
53. Schulman B.A., Carrano A.C., Jeffrey P.D., Bowen Z., Kinnucan E.R., Finnin M.S., Elledge S.J., Harper J.W., Pagano M., Pavletich N.P. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature. 408:2000;381-386.
54. Shen H.M., Peters A., Baron B., Zhu X., Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 280:1998;1750-1752.
55. Staudt L.M. Gene expression profiling of lymphoid malignancies. Annu. Rev. Med. 53:2002;303-318.
56. Stebbins C.E., Kaelin W.G. Jr., Pavletich N.P. Structure of the VHL-ElonginC-ElonginB complex. implications for VHL tumor suppressor function Science. 284:1999;455-461.
57. Sudol M., Sliwa K., Russo T. Functions of WW domains in the nucleus. FEBS Lett. 490:2001;190-195.
58. Terwilliger T.C., Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. D Biol. Crystallogr. 55:1999;849-861.
59. Toney L.M., Cattoretti G., Graf J.A., Merghoub T., Pandolfi P.P., Dalla-Favera R., Ye B.H., Dent A.L. BCL-6 regulates chemokine gene transcription in macrophages. Nat. Immunol. 1:2000;214-220.
60. Wang X., Li Z., Naganuma A., Ye B.H. Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc. Natl. Acad. Sci. USA. 99:2002;15018-15023.
61. Wong C.W., Privalsky M.L. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J. Biol. Chem. 273:1998;27695-27702.
62. Ye B.H. BCL-6 in the pathogenesis of non-Hodgkin's lymphoma. Cancer Invest. 18:2000;356-365.
63. Zelent A., Guidez F., Melnick A., Waxman S., Licht J.D. Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene. 20:2001;7186-7203.
64. Zhang H., Okada S., Hatano M., Okabe S., Tokuhisa T. A new functional domain of Bcl6 family that recruits histone deacetylases. Biochim. Biophys. Acta. 1540:2001;188-200.